In This Section

All Advocacy

Keep up with breaking news on policy decisions and legislation affecting biomedical research, research funding opportunities, regulations, and other important matters impacting pharmacology and pharmacologists.

Refine Results

Filter By Advocacy Type

October 23, 2024 ASPET Comments on NIH RFI on Recommendations on Re-envisioning U.S. Postdoctoral Research Training and Career Progression within the Biomedical Research Enterprise
AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Transforming Discoveries into Therapies ASPET 1801 Rockville Pike, Suite 210 Rockville, MD 20852 Office: 301-634-7060 aspet.org Submitted online via RFI website on October 23, 2024. RE: Recommendations on Re-envisioning U.S. Postdoctoral Research Training and Career Progression within the Biomed
August 19, 2024 ASPET Comments on NIH RFI Regarding the Draft Public Access Policy
AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Transforming Discoveries into Therapies ASPET 1801 Rockville Pike, Suite 210 Rockville, MD 20852 Office: 301-634-7060 aspet.org Submitted online via RFI website on August 19, 2024. RE: Request for Inormation: National Institutes of Health Draft Public Access Policy On behalf of the members of
August 16, 2024 ASPET Provides Comments on the House Energy and Commerce Committee Chair on NIH Reform Framework
AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Transforming Discoveries into Therapies ASPET 1801 Rockville Pike, Suite 210 Rockville, MD 20852 Office: 301-634-7060 aspet.org August 16, 2024 The Honorable Cathy McMorris Rodgers Chair, House Energy and Commerce Commitee United States House of Representatives Washington, D.C. 20515 RE: Req
August 8, 2024 ASPET Comments on NASEM Updates on the Guide for the Care and Use of Laboratory Animals
AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Transforming Discoveries into Therapies ASPET 1801 Rockville Pike, Suite 210 Rockville, MD 20852 Office: 301-634-7060 aspet.org August 8, 2024 Standing Committee for the Care and Use of Animals in Research National Academies of Science, Engineering, and Medicine Board on Animal Health
July 9, 2024 ASPET joined more than 200 organizations in a letter to the House Appropriations Committee leadership with concerns to science funding cuts.
July 9, 2024 The Hon. Tom Cole Chairman House Appropriations Committee H-307 The Capitol Washington, DC 20515 The Hon. Rosa DeLauro Ranking Member House Appropriations Committee 1036 Longworth House Office Building Washington, DC 20515 Dear Chairman Cole and Ranking Member DeLauro: We, the undersigned organizations, are writing to share our opposition to the Fiscal Year (FY)
April 1, 2024 ASPET joined the College of Problems of Drug Dependence statement on psychedelics
Summary. We, the undersigned academic scientists and representatives of organizations involved in treatment development for substance use disorders and professional therapeutic societies, are writing to express our support for expanded federal and private sector investments in clinical studies examining the potential of the class of psychedelic and dissociative medications for the treatment of
February 6, 2024 ASPET Comment Letter to NIST RFI Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights
AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Transforming Discoveries into Therapies ASPET 1801 Rockville Pike, Suite 210 Rockville, MD 20852 Office: 301-634-7060 aspet.org February 6, 2024 National Institute of Standards and Technology 100 Bureau Drive Gaithersburg, MD 20899 RE: Request for Information Regarding the Draft Interagency Guid
July 31, 2023 ASPET Comment Letter to NIH OLAW RFI on on Clarification of Animal Activities Exempt from the PHS Policy Requirements for IACUC Review
AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Transforming Discoveries into Therapies ASPET 1801 Rockville Pike, Suite 210 Rockville, MD 20852 Office: 301-634-7060 aspet.org July 31, 2023 Office of Laboratory Animal Welfare (OLAW) National Institutes of Health 6700B Rockledge Drive, Suite 2500, MSC 6910 Bethesda, MD 20892 RE: Request
October 11, 2023 ASPET Comment Letter to NIH OLAW RFI on Flexibilities for Streamlining IACUC Review of Protocols and Significant Changes
AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Transforming Discoveries into Therapies ASPET 1801 Rockville Pike, Suite 210 Rockville, MD 20852 Office: 301-634-7060 aspet.org October 11, 2023 Office of Laboratory Animal Welfare (OLAW) National Institutes of Health 6700B Rockledge Drive, Suite 2500, MSC 6910 Bethesda, MD 20892 RE: Reques
November 21, 2023 ASPET Comment Letter to NIH RFI on Inviting Comments and Suggestions on Updating the NIH Mission Statement
AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Transforming Discoveries into Therapies ASPET 1801 Rockville Pike, Suite 210 Rockville, MD 20852 Office: 301-634-7060 aspet.org November 21, 2023 Submitted via web portal RE: Request for Information (RFI) on Inviting Comments and Suggestions on Updating the NIH Mission Statement The Americ

In This Section

All Advocacy

Refine Results

Filter By Advocacy Type

Job Postings